文献速递消化道肿瘤放疗放疗物理与技术

直肠癌在线自适应放疗较计划选择策略的剂量获益量化

Online adaptive radiotherapy compared to plan selection for rectal cancer: quantifying the benefit.
PubMed 文献 · Radiat Oncol · 2020-07-08

该研究纳入2016年5月至9月接受计划选择策略(PS)治疗的首20例直肠癌患者(10例短程、10例长程),基于300次锥形束CT比较在线自适应放疗(ART)与PS的剂量差异。结果显示在线ART在不降低靶区覆盖的同时,显著降低危及器官剂量及接受95%处方剂量的正常组织体积。

要点

  • 在线ART靶区覆盖与PS相同,D99%无差异报告。
  • 接受95%处方剂量的正常组织中位体积从642 cm3降至237 cm3(p<0.001)。
  • 短程与长程放疗中在线ART均显著降低各测试剂量水平的危及器官剂量(p<0.001)。

核心结论

  • 在线自适应放疗较临床实施的计划选择策略显著降低直肠癌危及器官剂量,且不损害靶区覆盖。

研究设计与样本

  • 研究纳入2016年5月至9月接受计划选择策略治疗的首20例直肠癌患者,其中短程10例、长程10例,共获取300次锥形束CT。
  • 在线ART与PS策略均采用自动计划生成双弧VMAT计划,逐次在锥形束CT上勾画肠袋、膀胱和直肠系膜并计算每日DVH。

主要发现

  • 在线ART靶区覆盖保持不变,接受95%处方剂量的正常组织中位体积从642 cm3降至237 cm3(p<0.001)。
  • 长程放疗中肠袋V15Gy所有分次中位差异为-126 cm3,每例患者平均差异范围为-206 cm3至-40 cm3。
  • 短程放疗中肠袋V15Gy所有分次中位差异为-62 cm3,每例患者平均差异范围为-105 cm3至-51 cm3。
  • 长程放疗中膀胱V15Gy所有分次中位差异为26%,每例患者平均差异范围为-34%至12%。
  • 短程放疗中膀胱V95%所有分次中位差异为-8%,每例患者平均差异范围为-29%至0%。

关键数值与推荐

  • 在线ART与PS的靶区覆盖以99%CTV体积接受的剂量(D99%)计算,结果靶区覆盖保持不变。
  • 正常组织受照体积以接受95%处方分次剂量及以上的体积减去CTV体积计算。
  • 短程与长程放疗中在线ART在所有测试剂量水平均降低危及器官剂量(p<0.001)。

临床怎么用

  • 直肠癌在线自适应放疗可在不牺牲靶区覆盖的前提下显著降低肠袋和膀胱等危及器官剂量。
  • 与计划选择策略相比,在线ART减少接受95%处方剂量的正常组织体积,可能有利于降低肠道和膀胱毒性。

局限性

  • 研究仅纳入20例患者(短程10例、长程10例),样本量有限。
  • 研究为回顾性批准的单中心分析,未报告前瞻性随机对照结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To compare online adaptive radiation therapy (ART) to a clinically implemented plan selection strategy (PS) with respect to dose to the organs at risk (OAR) for rectal cancer. METHODS: The first 20 patients treated with PS between May-September 2016 were included. This resulted in 10 short (SCRT) and 10 long (LCRT) course radiotherapy treatment schedules with a total of 300 Conebeam CT scans (CBCT). New dual arc VMAT plans were generated using auto-planning for both the online ART and PS strategy. For each fraction bowel bag, bladder and mesorectum were delineated on daily Conebeam CTs. The dose distribution planned was used to calculate daily DVHs. Coverage of the CTV was calculated, as defined by the dose received by 99% of the CTV volume (D99%). The volume of normal tissue irradiated with 95% of the prescribed fraction dose was calculated by calculating the volume receiving 95% of the prescribed fraction or more dose minus the volume of the CTV. For each fraction the difference between the plan selection and online adaptive strategy of each DVH parameter was calculated, as well as the average difference per patient. RESULTS: Target coverage remained the same for online ART. The median volume of the normal tissue irradiated with 95% of the prescribed dose dropped from 642 cm3 (PS) to 237 cm3 (online-ART)(p < 0.001). Online ART reduced dose to the OARs for all tested dose levels for SCRT and LCRT (p < 0.001). For V15Gy of the bowel bag the median difference over all fractions of all patients was - 126 cm3 in LCRT, while the average difference per patient ranged from - 206 cm3 to - 40 cm3. For SCRT the median difference was - 62 cm3, while the range of the average difference per patient was - 105 cm3 to - 51 cm3. For V15Gy of the bladder the median difference over all fractions of all patients was 26% in LCRT, while the average difference per patient ranged from - 34 to 12%. For SCRT the median difference of V95% was - 8%, while the range of the average difference per patient was - 29 to 0%. CONCLUSIONS: Online ART for rectal cancer reduces dose the OARs significantly compared to a clinically implemented plan selection strategy, without compromising target coverage. TRIAL REGISTRATION: Medical Research Involving Human Subjects Act (WMO) does not apply to this study and was retrospectively approved by the Medical Ethics review Committee of the Academic Medical Center (W19_357 # 19.420; Amsterdam University Medical Centers, Location Academic Medical Center, Amsterdam, The Netherlands).

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. de Jong R, Crama KF, Visser J, et al. Online adaptive radiotherapy compared to plan selection for rectal cancer: quantifying the benefit. Radiat Oncol. 2020. PMID: 32641080. doi:10.1186/s13014-020-01597-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。